A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface

Rebekah L. Gundry, Kenneth R. Boheler, Jennifer E. Van Eyk, Bernd Wollscheid

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

The concept of cell-based therapy has been advocated as a novel approach for treating diseases or conditions where regeneration of cells, tissue and/or potentially organs is required. A promising source for cell-replacement therapies is provided by stem cells, but the success of this approach will ultimately rely on the ability to isolate primary stem or progenitor cells. Cell-surface protein markers will play a critical role in this step. Current methodologies for the identification of cell-surface protein markers rely primarily on antibody availability and flow cytometry, but many cell-surface proteins remain undetectable. Proteomic technologies now offer the possibility to specifically identify and investigate the cell-surface subproteome in a quantitative and discovery-driven manner. Once a cell surface protein marker panel has been identified by MS and the antibodies become available, the panel should permit the identification, tracking, and/or isolation of stem or progenitor cells that may be appropriate for therapeutics. This review provides a context for the use of proteomics in discovering new cell-surface markers for stem cells.

Original languageEnglish (US)
Pages (from-to)892-903
Number of pages12
JournalProteomics - Clinical Applications
Volume2
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Stem cells
Proteomics
Membrane Proteins
Stem Cells
Cell- and Tissue-Based Therapy
Flow cytometry
Antibodies
Availability
Tissue
Regeneration
Flow Cytometry
Technology

Keywords

  • Cell surface protein marker
  • Stem cells

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

A novel role for proteomics in the discovery of cell-surface markers on stem cells : Scratching the surface. / Gundry, Rebekah L.; Boheler, Kenneth R.; Van Eyk, Jennifer E.; Wollscheid, Bernd.

In: Proteomics - Clinical Applications, Vol. 2, No. 6, 01.06.2008, p. 892-903.

Research output: Contribution to journalReview article

Gundry, Rebekah L. ; Boheler, Kenneth R. ; Van Eyk, Jennifer E. ; Wollscheid, Bernd. / A novel role for proteomics in the discovery of cell-surface markers on stem cells : Scratching the surface. In: Proteomics - Clinical Applications. 2008 ; Vol. 2, No. 6. pp. 892-903.
@article{a534c4c3922143b4990a4a970430bd56,
title = "A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface",
abstract = "The concept of cell-based therapy has been advocated as a novel approach for treating diseases or conditions where regeneration of cells, tissue and/or potentially organs is required. A promising source for cell-replacement therapies is provided by stem cells, but the success of this approach will ultimately rely on the ability to isolate primary stem or progenitor cells. Cell-surface protein markers will play a critical role in this step. Current methodologies for the identification of cell-surface protein markers rely primarily on antibody availability and flow cytometry, but many cell-surface proteins remain undetectable. Proteomic technologies now offer the possibility to specifically identify and investigate the cell-surface subproteome in a quantitative and discovery-driven manner. Once a cell surface protein marker panel has been identified by MS and the antibodies become available, the panel should permit the identification, tracking, and/or isolation of stem or progenitor cells that may be appropriate for therapeutics. This review provides a context for the use of proteomics in discovering new cell-surface markers for stem cells.",
keywords = "Cell surface protein marker, Stem cells",
author = "Gundry, {Rebekah L.} and Boheler, {Kenneth R.} and {Van Eyk}, {Jennifer E.} and Bernd Wollscheid",
year = "2008",
month = "6",
day = "1",
doi = "10.1002/prca.200780122",
language = "English (US)",
volume = "2",
pages = "892--903",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - A novel role for proteomics in the discovery of cell-surface markers on stem cells

T2 - Scratching the surface

AU - Gundry, Rebekah L.

AU - Boheler, Kenneth R.

AU - Van Eyk, Jennifer E.

AU - Wollscheid, Bernd

PY - 2008/6/1

Y1 - 2008/6/1

N2 - The concept of cell-based therapy has been advocated as a novel approach for treating diseases or conditions where regeneration of cells, tissue and/or potentially organs is required. A promising source for cell-replacement therapies is provided by stem cells, but the success of this approach will ultimately rely on the ability to isolate primary stem or progenitor cells. Cell-surface protein markers will play a critical role in this step. Current methodologies for the identification of cell-surface protein markers rely primarily on antibody availability and flow cytometry, but many cell-surface proteins remain undetectable. Proteomic technologies now offer the possibility to specifically identify and investigate the cell-surface subproteome in a quantitative and discovery-driven manner. Once a cell surface protein marker panel has been identified by MS and the antibodies become available, the panel should permit the identification, tracking, and/or isolation of stem or progenitor cells that may be appropriate for therapeutics. This review provides a context for the use of proteomics in discovering new cell-surface markers for stem cells.

AB - The concept of cell-based therapy has been advocated as a novel approach for treating diseases or conditions where regeneration of cells, tissue and/or potentially organs is required. A promising source for cell-replacement therapies is provided by stem cells, but the success of this approach will ultimately rely on the ability to isolate primary stem or progenitor cells. Cell-surface protein markers will play a critical role in this step. Current methodologies for the identification of cell-surface protein markers rely primarily on antibody availability and flow cytometry, but many cell-surface proteins remain undetectable. Proteomic technologies now offer the possibility to specifically identify and investigate the cell-surface subproteome in a quantitative and discovery-driven manner. Once a cell surface protein marker panel has been identified by MS and the antibodies become available, the panel should permit the identification, tracking, and/or isolation of stem or progenitor cells that may be appropriate for therapeutics. This review provides a context for the use of proteomics in discovering new cell-surface markers for stem cells.

KW - Cell surface protein marker

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=46749104456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749104456&partnerID=8YFLogxK

U2 - 10.1002/prca.200780122

DO - 10.1002/prca.200780122

M3 - Review article

C2 - 19526049

AN - SCOPUS:46749104456

VL - 2

SP - 892

EP - 903

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 6

ER -